Use of Wearable Digital Sensors After mRNA Vaccination in Adults

PreclinicalCompleted
0 views this week 0 watching
0
Hype Score

Development Stage

1
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Healthy Participants

Conditions

Healthy Participants

Trial Timeline

Jun 16, 2022 → Feb 7, 2023

About Use of Wearable Digital Sensors After mRNA Vaccination in Adults

Use of Wearable Digital Sensors After mRNA Vaccination in Adults is a preclinical stage product being developed by Moderna for Healthy Participants. The current trial status is completed. This product is registered under clinical trial identifier NCT05440318. Target conditions include Healthy Participants.

What happened to similar drugs?

20 of 20 similar drugs in Healthy Participants were approved

Approved (20) Terminated (1) Active (0)

Clinical Trials (1)

NCT IDPhaseStatus
NCT05440318PreclinicalCompleted

Competing Products

20 competing products in Healthy Participants

See all competitors
ProductCompanyStageHype Score
mRNA-0184ModernaPhase 1
0
mRNA-6231ModernaPhase 1
0
LetrozoleDr. Reddy's LaboratoriesPhase 1
26
IsotretinoinDr. Reddy's LaboratoriesPhase 1
26
FexofenadineDr. Reddy's LaboratoriesPhase 1
26
SertralineDr. Reddy's LaboratoriesPhase 1
26
Nizatidine + AxidDr. Reddy's LaboratoriesPhase 1
26
AnastrozoleDr. Reddy's LaboratoriesPhase 1
26
mRNA-1273.712ModernaApproved
0
RisperidoneDr. Reddy's LaboratoriesPhase 1
26
LamotrigineDr. Reddy's LaboratoriesPhase 1
26
Metformin + GlucophageDr. Reddy's LaboratoriesPhase 1
26
LamotrigineDr. Reddy's LaboratoriesPhase 1
26
mRNA-0184ModernaPhase 1
0
Divalproex SodiumDr. Reddy's LaboratoriesPhase 1
26
SirolimusDr. Reddy's LaboratoriesPhase 1
26
GlimepirideDr. Reddy's LaboratoriesPhase 1
26
Ziprasidone HydrochlorideDr. Reddy's LaboratoriesPhase 1
26
Naproxen sodiumDr. Reddy's LaboratoriesPhase 1
26
LansoprazoleDr. Reddy's LaboratoriesPhase 1
26